Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors (Q89113843)
Jump to navigation
Jump to search
scientific article published on 15 June 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors |
scientific article published on 15 June 2018 |
Statements
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors (English)
Colin D Weekes
Lee S Rosen
Anna Capasso
Kit Man Wong
Maria Anderson
Bruce McCall
Jill Fredrickson
Eric Wakshull
Steve Eppler
Quyen Shon-Nguyen
Rupal Desai
Mahrukh Huseni
Priti S Hegde
Tony Pourmohamad
Ina Rhee